Cargando…

Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury

Growing evidence has shown that gut microbiome is a key factor involved in liver health. Therefore, gut microbiota modulation with probiotic bacteria, such as Saccharomyces boulardii, constitutes a promising therapy for hepatosis. In this study, we aimed to investigate the protective effects of S. b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Lei, Zhao, Xue-ke, Cheng, Ming-liang, Yang, Guo-zhen, Wang, Bi, Liu, Hua-juan, Hu, Ya-xin, Zhu, Li-li, Zhang, Shuai, Xiao, Zi-wen, Liu, Yong-mei, Zhang, Bao-fang, Mu, Mao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430957/ https://www.ncbi.nlm.nih.gov/pubmed/28465509 http://dx.doi.org/10.1038/s41598-017-01271-9

Ejemplares similares

Effect of Saccharomyces boulardii and Bacillus subtilis B10 on gut microbiota modulation in broilers
por: Qin, Chubin, et al.
Publicado: (2018)

Administration of Saccharomyces boulardii mafic-1701 improves feed conversion ratio, promotes antioxidant capacity, alleviates intestinal inflammation and modulates gut microbiota in weaned piglets
por: Zhang, Wenxiu, et al.
Publicado: (2020)

Comparison of the Effects of Enzymolysis Seaweed Powder and Saccharomyces boulardii on Intestinal Health and Microbiota Composition in Kittens
por: Zhang, Mingrui, et al.
Publicado: (2023)

Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system
por: Stier, Heike, et al.
Publicado: (2016)

Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice
por: Zhou, Huan, et al.
Publicado: (2018)

Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiota
por: Spatz, Madeleine, et al.
Publicado: (2023)

Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
por: Sulik-Tyszka, Beata, et al.
Publicado: (2017)

Biocontainment strategies for in vivo applications of Saccharomyces boulardii
por: Hedin, Karl Alex, et al.
Publicado: (2023)

Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice
por: Everard, Amandine, et al.
Publicado: (2014)

Impact of Saccharomyces boulardii on jaundice in premature infants undergoing phototherapy
por: Hu, Di, et al.
Publicado: (2022)

Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?
por: Pais, Pedro, et al.
Publicado: (2020)

Intraperitoneal Administration of Fetuin-A Attenuates d-Galactosamine/Lipopolysaccharide-Induced Liver Failure in Mouse
por: Zhang, Pan, et al.
Publicado: (2014)

Effect of Saccharomyces boulardii and Mode of Delivery on the Early Development of the Gut Microbial Community in Preterm Infants
por: Zeber-Lubecka, Natalia, et al.
Publicado: (2016)

Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profile
por: Gao, Hui, et al.
Publicado: (2023)

Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers
por: Kabbani, Toufic A., et al.
Publicado: (2016)

Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota
por: Fang, Daiqiong, et al.
Publicado: (2017)

Saccharomyces boulardii improves the behaviour and emotions of spastic cerebral palsy rats through the gut-brain axis pathway
por: Tao, Deshuang, et al.
Publicado: (2021)

Effects of Saccharomyces boulardii Supplementation on Nutritional Status, Fecal Parameters, Microbiota, and Mycobiota in Breeding Adult Dogs
por: Meineri, Giorgia, et al.
Publicado: (2022)

An unexpected allergic reaction with Saccharomyces boulardii: a case report
por: Kartal, Ozgur, et al.
Publicado: (2014)

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment
por: Appel-da-Silva, Marcelo C., et al.
Publicado: (2017)

The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children
por: Bin, Zhang, et al.
Publicado: (2015)

Luzindole attenuates LPS/d-galactosamine-induced acute hepatitis in mice
por: Luo, Yisheng, et al.
Publicado: (2019)

Saccharomyces boulardii modulates necrotizing enterocolitis in neonatal mice by regulating the sirtuin 1/NF-κB pathway and the intestinal microbiota
por: Zhang, Kun, et al.
Publicado: (2020)

Oral Administration of Recombinant Saccharomyces boulardii Expressing Ovalbumin-CPE Fusion Protein Induces Antibody Response in Mice
por: Bagherpour, Ghasem, et al.
Publicado: (2018)

Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota
por: Wang, Chunsaier, et al.
Publicado: (2019)

Saccharomyces boulardii modulates oxidative stress and renin angiotensin system attenuating diabetes-induced liver injury in mice
por: Barssotti, Leticia, et al.
Publicado: (2021)

Enhanced Production of β-Nicotinamide Mononucleotide with Exogenous Nicotinamide Addition in Saccharomyces boulardii-YS01
por: Song, Meijie, et al.
Publicado: (2023)

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review
por: Moré, Margret I, et al.
Publicado: (2015)

Heterologous Expression of the Leuconostoc Bacteriocin Leucocin C in Probiotic Yeast Saccharomyces boulardii
por: Li, Ran, et al.
Publicado: (2020)

Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
por: Awoyemi, Ayodeji, et al.
Publicado: (2021)

Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin
por: Lolis, Nikolaos, et al.
Publicado: (2008)

Modification of Salmonella Typhimurium Motility by the Probiotic Yeast Strain Saccharomyces boulardii
por: Pontier-Bres, Rodolphe, et al.
Publicado: (2012)

Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice
por: Maioli, Tatiani Uceli, et al.
Publicado: (2014)

Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System
por: Hudson, Lauren E., et al.
Publicado: (2016)

Saccharomyces cerevisiae boulardii Reduces the Deoxynivalenol-Induced Alteration of the Intestinal Transcriptome
por: Alassane-Kpembi, Imourana, et al.
Publicado: (2018)

Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii
por: Khatri, Indu, et al.
Publicado: (2017)

Growth Parameters and Survivability of Saccharomyces boulardii for Probiotic Alcoholic Beverages Development
por: de Paula, Breno Pereira, et al.
Publicado: (2019)

Both Saccharomyces boulardii and Its Postbiotics Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, Association with Modulating Inflammation and Intestinal Microbiota
por: Xu, Xinge, et al.
Publicado: (2023)

Rice Bran Fermented with Saccharomyces boulardii Generates Novel Metabolite Profiles with Bioactivity
por: Ryan, Elizabeth P., et al.
Publicado: (2011)

Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardii
por: Hudson, Lauren E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vnb2j0bmsnntip9fm8i5h17u04